Clinical intravoxel incoherent motion and diffusion MR imaging: past, present, and future

M Iima, D Le Bihan - Radiology, 2016 - pubs.rsna.org
The concept of diffusion magnetic resonance (MR) imaging emerged in the mid-1980s,
together with the first images of water diffusion in the human brain, as a way to probe tissue …

Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review

C Ferreli, G Gasparini, A Parodi, E Cozzani… - Clinical reviews in …, 2017 - Springer
Scleroderma refers to an autoimmune connective tissue fibrosing disease, including three
different subsets: localized scleroderma, limited cutaneous systemic sclerosis, and diffuse …

Biodistribution of gadolinium‐based contrast agents, including gadolinium deposition

S Aime, P Caravan - … Resonance Imaging: An Official Journal of …, 2009 - Wiley Online Library
The biodistribution of approved gadolinium (Gd)‐based contrast agents (GBCAs) is
reviewed. After intravenous injection GBCAs distribute in the blood and the extracellular …

[HTML][HTML] Smart magnetic resonance imaging-based theranostics for cancer

B Brito, TW Price, J Gallo, M Bañobre-López… - Theranostics, 2021 - ncbi.nlm.nih.gov
Smart theranostics are dynamic platforms that integrate multiple functions, including at least
imaging, therapy, and responsiveness, in a single agent. This review showcases a variety of …

What nephrologists need to know about gadolinium

JG Penfield, RF Reilly Jr - Nature clinical practice Nephrology, 2007 - nature.com
Gadolinium chelates are commonly used to improve tissue contrast in MRI. Until recently the
use of gadolinium was thought to be risk-free compared with alternative contrast agents …

Current status of gadolinium toxicity in patients with kidney disease

MA Perazella - Clinical Journal of the American Society of …, 2009 - journals.lww.com
Gadolinium-based contrast (GBC) agents have recently been the subject of intense interest
for physicians across numerous specialties. These agents are widely used as contrast for …

Biochemical safety profiles of gadolinium‐based extracellular contrast agents and nephrogenic systemic fibrosis

H Ersoy, FJ Rybicki - … Resonance Imaging: An Official Journal of …, 2007 - Wiley Online Library
Gadolinium (Gd)‐based paramagnetic contrast agents are relatively safe when used in
clinically recommended doses. However, with the rapidly expanding body of literature …

High levels of gadolinium deposition in the skin of a patient with normal renal function

DR Roberts, SM Lindhorst, CT Welsh… - Investigative …, 2016 - journals.lww.com
Objective The aim of this study was to assess gadolinium deposition in the skin of a patient
with normal renal function, based on estimated glomerular filtration rate values greater than …

Nephrogenic Systemic Fibrosis: Incidence, Associations, and Effect of Risk Factor Assessment—Report of 33 Cases1

J Perez-Rodriguez, S Lai, BD Ehst, DM Fine… - Radiology, 2009 - pubs.rsna.org
Purpose: To describe the presentation and clinical course of patients with nephrogenic
systemic fibrosis (NSF) at a large acute-care hospital, to evaluate the overall incidence of …

Ultrasmall iron oxide nanoparticles: Synthesis, surface modification, assembly, and biomedical applications

C Song, W Sun, Y Xiao, X Shi - Drug discovery today, 2019 - Elsevier
Highlights•Various synthetic strategies used to synthesize USIO NPs are
summarized.•Diverse surface modification and assembly methods of USIO NPs are …